Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × kang-lai-te × Clear all
NCT00733850 2015-06-19

Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer

KangLaiTe USA

Phase 2 Completed
85 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01640730 2014-01-16

Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer

KangLaiTe USA

Phase 2 Terminated
1 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00031031 2007-11-27

Kanglaite Injection Phase I Study

KangLaiTe USA

Phase 1 Completed
16 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡